Related references
Note: Only part of the references are listed.Etanercept as prophylactic psoriatic therapy before interferon-α and ribavirin treatment for active hepatitis C infection
S. E. Behnam et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2010)
Infliximab-induced acute hepatitis during Crohn's disease therapy: Absence of cross-toxicity with adalimumab
A. Haennig et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2010)
Viral Hepatitis and Inflammatory Bowel Disease
Jason K. Hou et al.
INFLAMMATORY BOWEL DISEASES (2010)
Infliximab-related hepatitis: discussion of a case and review of the literature
Stefano Mancini et al.
INTERNAL AND EMERGENCY MEDICINE (2010)
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: Preliminary data
Eleonora Annichiarico et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Efficiency and Safety of Etanercept after Acute Hepatitis Induced by Infliximab for Psoriasis
Nicolas Kluger et al.
ACTA DERMATO-VENEREOLOGICA (2009)
British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009
C. H. Smith et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients
Sophia Li et al.
CLINICAL RHEUMATOLOGY (2009)
Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept
K. M. Carlsen et al.
CLINICAL RHEUMATOLOGY (2009)
Switch from etanercept to efalizumab in a psoriatic patient with HCV infection: a case report
F. Prignano et al.
DERMATOLOGIC THERAPY (2009)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate
Howard Amital et al.
RHEUMATOLOGY (2009)
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008
D. E. Furst et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases
I. Cavazzana et al.
AUTOIMMUNITY REVIEWS (2008)
Histological evaluation of liver in two rheumatoid arthritis patients with chronic hepatitis B and C treated with TNF-alpha blockade: case reports
Primal P. Kaur et al.
CLINICAL RHEUMATOLOGY (2008)
Infliximab-induced hepatitis: absence of cross-toxicity with etanercept
Gerard Thiefin et al.
JOINT BONE SPINE (2008)
Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection
A. J. Alcaide et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Incidence and risk factors for psoriasis in the general population
Consuelo Huerta et al.
ARCHIVES OF DERMATOLOGY (2007)
Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C
Alper Yurci et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2007)
Combination therapy with cyclosporine A and anti-TNF-α agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection
Francesca Bellisai et al.
CLINICAL RHEUMATOLOGY (2007)
Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease
Manal F. Abdelmalek et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Epidemiology of hepatitis C virus infection
Miriam J. Alter
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab
Angel M. Garcia Aparicio et al.
CLINICAL RHEUMATOLOGY (2007)
Inhibition of TNFα does not induce viral reactivation in patients with chronic hepatitis C infection:: two cases
S. Aslanidis et al.
CLINICAL RHEUMATOLOGY (2007)
Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus
H. Marotte et al.
RHEUMATOLOGY (2007)
Safety of anti-TNF-α therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis
C. H. Roux et al.
RHEUMATOLOGY (2006)
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients
Mauro Galeazzi et al.
AUTOIMMUNITY REVIEWS (2006)
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
Gregory L. Armstrong et al.
ANNALS OF INTERNAL MEDICINE (2006)
Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection
C Rokhsar et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C
Clara De Simone et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis
L Tilling et al.
CLINICAL DRUG INVESTIGATION (2006)
Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study
NN Zein
JOURNAL OF HEPATOLOGY (2005)
Global epidemiology of hepatitis C virus infection
CW Shepard et al.
LANCET INFECTIOUS DISEASES (2005)
Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia
MO Chandesris et al.
RHEUMATOLOGY (2004)
Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection
LH Calabrese et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection
FA Parke et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases
MA Magliocco et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection
JR Peterson et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Efficacy of the anti-TNF-α antibody infliximab against refractory systemic vasculitides:: an open pilot study on 10 patients
P Bartolucci et al.
RHEUMATOLOGY (2002)
Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection
S Campbell et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2001)
Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFα receptors
L Berg et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C
Y Arase et al.
JOURNAL OF GASTROENTEROLOGY (2000)
Share Paper
